Cosciens Biopharma Stock Market Value
| CSCI Stock | 2.90 0.05 1.75% |
| Symbol | COSCIENS |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of COSCIENS Biopharma. If investors know COSCIENS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about COSCIENS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 3.759 | Quarterly Revenue Growth 0.041 | Return On Assets (0.23) | Return On Equity (0.66) |
The market value of COSCIENS Biopharma is measured differently than its book value, which is the value of COSCIENS that is recorded on the company's balance sheet. Investors also form their own opinion of COSCIENS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is COSCIENS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because COSCIENS Biopharma's market value can be influenced by many factors that don't directly affect COSCIENS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between COSCIENS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if COSCIENS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, COSCIENS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
COSCIENS Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to COSCIENS Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of COSCIENS Biopharma.
| 11/17/2024 |
| 12/17/2024 |
If you would invest 0.00 in COSCIENS Biopharma on November 17, 2024 and sell it all today you would earn a total of 0.00 from holding COSCIENS Biopharma or generate 0.0% return on investment in COSCIENS Biopharma over 30 days. COSCIENS Biopharma is related to or competes with Puma Biotechnology, Syndax Pharmaceuticals, and Protagonist Therapeutics. COSCIENS Biopharma is entity of United States More
COSCIENS Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure COSCIENS Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess COSCIENS Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 15.52 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 5.34 |
COSCIENS Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for COSCIENS Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as COSCIENS Biopharma's standard deviation. In reality, there are many statistical measures that can use COSCIENS Biopharma historical prices to predict the future COSCIENS Biopharma's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | (1.62) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of COSCIENS Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
COSCIENS Biopharma Backtested Returns
COSCIENS Biopharma secures Sharpe Ratio (or Efficiency) of -0.17, which signifies that the company had a -0.17% return per unit of volatility over the last 3 months. COSCIENS Biopharma exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm COSCIENS Biopharma's risk adjusted performance of (0.09), and Mean Deviation of 2.26 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.28, which signifies not very significant fluctuations relative to the market. As returns on the market increase, COSCIENS Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding COSCIENS Biopharma is expected to be smaller as well. At this point, COSCIENS Biopharma has a negative expected return of -0.55%. Please make sure to confirm COSCIENS Biopharma's jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if COSCIENS Biopharma performance from the past will be repeated at future time.
Auto-correlation | 0.05 |
Virtually no predictability
COSCIENS Biopharma has virtually no predictability. Overlapping area represents the amount of predictability between COSCIENS Biopharma time series from 17th of November 2024 to 2nd of December 2024 and 2nd of December 2024 to 17th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of COSCIENS Biopharma price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current COSCIENS Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | 0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
COSCIENS Biopharma lagged returns against current returns
Autocorrelation, which is COSCIENS Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting COSCIENS Biopharma's stock expected returns. We can calculate the autocorrelation of COSCIENS Biopharma returns to help us make a trade decision. For example, suppose you find that COSCIENS Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
COSCIENS Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If COSCIENS Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if COSCIENS Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in COSCIENS Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
COSCIENS Biopharma Lagged Returns
When evaluating COSCIENS Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of COSCIENS Biopharma stock have on its future price. COSCIENS Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, COSCIENS Biopharma autocorrelation shows the relationship between COSCIENS Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in COSCIENS Biopharma.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether COSCIENS Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of COSCIENS Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cosciens Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cosciens Biopharma Stock:Check out COSCIENS Biopharma Correlation, COSCIENS Biopharma Volatility and COSCIENS Biopharma Alpha and Beta module to complement your research on COSCIENS Biopharma. For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
COSCIENS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.